A first-in-human phase I trial with antibody drug conjugate ADCT-701 in neuroendocrine tumors and carcinomas

被引：0

作者：

Del Rivero, Jaydira

Glod, John

Magee, Tamika

Cooper, Kimberley

Rivero, Anna

Lanfranconi, Tea

Patel, Rashmika

Figg, W. Douglas

Pommier, Yves

Widemann, Brigitte C.

Roper, Nitin

机构：

[1] NCI, Dev Therapeut Branch, NIH, Bethesda, MD USA

[2] NCI, Pediat Oncol Branch, NIH, Bethesda, MD USA

[3] NCI, NIH, Bethesda, MD USA

[4] NCI, Ctr Canc Res, Bethesda, MD USA

[5] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD USA

[6] NCI, Pediat Oncol Branch, NIH, Bethesda, MD USA

来源：

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.TPS672

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：TPS672 / TPS672

页数：1